The cellular target of curvularol, a G 1 -specific cellcycle inhibitor of mammalian cells, was identified by a genetic approach in Saccharomyces cerevisiae. Since the wild-type W303 strain was highly resistant to curvularol, a drug hypersensitive parental strain was constructed in which various genes implicated in general drug resistance had been disrupted. Curvularol resistant mutants were isolated, and strains that exhibited a semi-dominant, curvularol-specific resistance phenotype were selected. All five strains examined were classified into a single genetic complementation group designated YCR1. A mutant gene responsible for curvularol resistance was identified as an allele of the RPL3 gene encoding the ribosomal protein L3. Sequence analysis of the mutant genes revealed that Trp255Cys and Trp255Leu substitutions of Rpl3p are responsible for curvularol resistance. Rpl3p mutants in which Trp255 residue was replaced by other amino acids were constructed. All of these replacements led to varying degrees of increased resistance to curvularol and growth defects.
The cellular target of curvularol, a G 1 -specific cellcycle inhibitor of mammalian cells, was identified by a genetic approach in Saccharomyces cerevisiae. Since the wild-type W303 strain was highly resistant to curvularol, a drug hypersensitive parental strain was constructed in which various genes implicated in general drug resistance had been disrupted. Curvularol resistant mutants were isolated, and strains that exhibited a semi-dominant, curvularol-specific resistance phenotype were selected. All five strains examined were classified into a single genetic complementation group designated YCR1. A mutant gene responsible for curvularol resistance was identified as an allele of the RPL3 gene encoding the ribosomal protein L3. Sequence analysis of the mutant genes revealed that Trp255Cys and Trp255Leu substitutions of Rpl3p are responsible for curvularol resistance. Rpl3p mutants in which Trp255 residue was replaced by other amino acids were constructed. All of these replacements led to varying degrees of increased resistance to curvularol and growth defects.
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Small-molecule bioactive compounds are acquiring increasing interest in basic research in manipulating cellular physiology, as well as in medicine in the treatment of various diseases, including cancer. A large number of bioactive compounds have been discovered through screening for their biological effects using various screening systems that utilize living organisms, including prokaryotic and eukaryotic microorganisms, and tissue culture cells. But, the action mechanisms by which these compounds elicit their biological effects from the cells often remain to be elucidated.
Small-molecule bioactive compounds are thought to elicit their biological effects by specific binding to the cellular target molecule, which plays a vital role in cell viability. The accumulating data suggest that many bioactive compounds act universally throughout the eukaryotes in an evolutionarily conserved manner, sharing a structurally and functionally conserved target molecule. The remarkable generality in drug action mechanisms, together with the powerful genetic techniques available in yeast, provide an ideal model system for investigation of the diverse biological effects of bioactive compounds at the molecular level.
If the specific interaction between a small-molecule bioactive compound and its target in yeast is disrupted by mutations within the target molecule, the mutation results in a dominant or semi-dominant phenotype specifically resistant to this particular compound (and to certain structurally related compounds). Based on this assumption, recently we identified isoleucyl tRNA synthetase is as a target of reveromycin A, a G 1 -specific inhibitor which was discovered in a screening system that utilizes mammalian culture cells. 1) In the present study, we identified by a similar approach a target of curvularol (CUR), a G 1 -specific inhibitor of mammalian cells, structurally related to the trichothecene-family compounds (Fig. 1) . 2) We found that all five semidominant, CUR resistant mutations (YCR1-1 to -5; yeast curvularol resistance) of Saccharomyces cerevisiae were alleles of the RPL3 gene, which encodes the ribosomal large subunit protein L3.
Materials and Methods
Strains. All S. cerevisiae strains are derivatives of strain W303. The strains used were the following: W303-1A strain (MATa ade2 his3 leu2 trp1 ura3 can1-100), YFK11 (MATa pdr1Á::hisG-URA3-hisG pdr3Á:: hisG-URA3-hisG), YFK13 (MATa pdr5Á::LEU2), YFK17 (MATa pdr5Á::LEU2 pdr1Á::hisG-URA3-hisG y To whom correspondence should be addressed. Tel: +81-824-24-7763; Fax: +81-824-24-7045; E-mail: tmiyaka@hiroshima-u.ac.jp Abbreviations: CUR, curvularol; FACS, fluorescence activated cell sorting; PCR, polymerase chain reaction; SD, synthetic complete medium containing dextrose; YPD, yeast peptone dextrose; WT, wild type pdr3Á::hisG-URA3-hisG), YFK19 (MATa TRP1 erg3Á::HIS3 pdr5Á::LEU2 pdr1Á::hisG-URA3-hisG pdr3Á::hisG-URA3-hisG), YFK30 (isogenic to YFK19 but eliminated for the URA3 marker, which was integrated in PDR1, and PDR3 loci, by cultivating the cells in a 5-fluoroorotic acid-containing medium), YFK31 (RPL3/rpl3Á diploid strain, otherwise isogenic to the diploid of YFK30 strain). For plasmid preparation, Escherichia coli DH5 supE44, ÁlacU169 (80 lacZÁ M15) hsdR17 recA1 endA1 gryA96 thi-1 relA1 was used.
[
35 S]Methionine incorporation. Strains were grown at 28 C in synthetic minimal medium without methionine. Exponentially growing culture of YFK30 strain was incubated with CUR (0.8 mg/ml) or cycloheximide (0.08 mg/ml) for 60 min. The incorporation of [
35 S] methionine was assessed by incubating 100 ml aliquots of the treated cell cultures in the presence of the labeled amino acid for 7 min, and the reaction was stopped by the addition of 200 ml of 20% TCA. The samples were filtered through a membrane filter, and the radioactivity that remained on the filter was determined by liquid scintillation counting. Values for each culture were calculated by dividing by the number of cells. The ratio of [
35 S] methionine incorporation was calculated by dividing this value by the value similarly obtained at the start of incubation.
Cloning of the YCR1-1 mutant gene. Total genomic DNA of the YCR1-1 strain was partially digested with the restriction enzyme Sau3A I, and the DNA fragments of 7-to 10-kb were recovered by sucrose gradient centrifugation. A YCR1-1 genomic DNA library was constructed by ligation to the BamH I digested, and dephosphorylated YCp50 centromeric vector (URA3 marker). This library was used to transform the YFK30 strain. About 30,000 transformants were picked up on a YPD plate containing 0.7 mg/ml of CUR, and the plate was incubated at 30 C for 3 d. Plasmids were recovered from the resistant colonies, passaged through E. coli, and reintroduced to the YFK30 strain for confirmation of plasmid-born CUR resistance.
Construction of plasmids containing various RPL3
mutant alleles. The full-length RPL3 gene was amplified from genomic DNA by PCR using oligonucleotide primers 5 0 -AAAGAATTCTGTTAGTGCCGCTCGTA-TCAG-3 0 (EcoR I site is underlined), 5 0 -AAAAAGCTT-CCAGGGTGATGTAACAGAGGG-3 0 (the Hind III site is underlined), and mutagenic primers 5 0 -CTTGTATT-GGTGCTXXXCATCCAGCCCACG-3 0 and 5 0 -CGTG-GGCTGGATGYYYAGCACCAATACAAG-3 0 ; for the sequences of XXX and YYY, see Table 1 . Each product was cloned into pRS316 digested with EcoR I and Hind III to make pRS316-RPL3 Trp255X (X: any amino acid) series of plasmids. The mutations were confirmed by DNA sequencing. pRS414-RPL3
Trp255X plasmid was constructed by ligation of the EcoR I-Xho I fragment of pRS316-RPL3
Trp255X with EcoR I-and Xho I-digested pRS414.
Construction of rpl3Á strain transformants relying on rpl3 mutant alleles. A diploid strain heterozygous (RPL3/rpl3Á) for the RPL3 locus was constructed by gene replacement of one of the RPL3 locus, as follows: The full-length RPL3 gene was amplified from genomic DNA by PCR using oligonucleotide primers 5 0 -AA-AGAATTCTCTTTCGTGCTTCCTGGA-3 0 (the EcoR I site is underlined) and 5 0 -AAAAAGCTTCTTACAA-GTCCTTCTTC-3 0 (the Hind III site is underlined). The EcoR I-Hind III fragment of the PCR product was subcloned into BlueScript KS digested with EcoR I and Hind III. The resulting plasmid was digested with Bgl II and Mun I and ligated with the BamH I-EcoR I fragment of the kanMX4 cassette. The EcoR I-Bgl I fragment of this plasmid was used to transform a diploid YFK30 strain. Correct replacement of the deleted allele was confirmed by PCR, and the resulting strain was designated the YFK31 strain.
Each of the pRS316-RPL3 Trp255X plasmids was then introduced into the YFK31 strain. The diploid transformants were then sporulated and the spores were dissected. Strains showing both Ura þ and Kan r phenotypes were isolated.
DNA sequencing. DNA sequencing was done with an ABI PRISM 3100-Avant Genetic Analyzer (Applied Biosystems, Foster City, CA). For the PCR reaction, a BigDye Ò Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) was used.
Results
Construction of a parental strain for isolation of CUR-resistant mutants CUR has been reported to exhibit only a marginal inhibitory effect on the growth of wild-type (WT) yeasts.
2) In accordance with previous observations, WT laboratory S. cerevisiae strain W303-1A was found to be highly resistant to CUR, and grew apparently normally in a medium containing 10 mg/ml of the drug (higher concentrations were not tested). To increase the CUR 2)
sensitivity of the WT strain, we examined the effect of the deletion of various genes implicated in general drug resistance. The ATP-binding cassette superfamily transporter protein Pdr5p and two homologous Zn(II) 2 Cys 6 -type transcription factors Pdr1p/Pdr3p for pleiotropic drug resistance are important in the resistance of the yeast to a variety of drugs. 3, 4) Membrane ergosterol is also important in the resistance of yeasts to xenobiotic compounds. A mutant defective in the ERG3 gene encoding an enzyme of ergosterol synthesis showed increased sensitivity to xenobiotics. 5) We examined the effect of deletion of the genes implicated in unspecific drug resistance on the growth of the WT strain on YPD solid medium containing various concentrations of CUR (Fig. 2) . The CUR sensitivity of the strains with the deleted genes for Pdr1p and Pdr3p in combination (pdr1Á pdr3Á), Pdr5p (pdr5Á), or Erg3p (erg3Á) was compared, and each construct was found to exhibit increased sensitivity to CUR compared to WT strain. The quadruplex deletion strain (YFK30), in which all of these genes were deleted in combination (pdr1Á pdr3Á pdr5Á erg3Á), exhibited the highest sensitivity to CUR. The growth of the YFK30 strain was almost completely inhibited by 0.5 mg/ml of CUR (Fig. 2) .
Next, we investigated the physiological effect of CUR on yeast using the YFK30 strain. In YPD liquid medium containing various concentrations of CUR, the growth of this strain was nearly completely inhibited by 1.0 mg/ml of the drug (see below; Fig. 4A ). FACS analysis of the cells cultivated in the medium containing CUR revealed that the growth inhibition was accompanied by an increase in the 1C DNA peak (see below; Fig. 4B ). The effect of CUR on the incorporation of [
35 S] methionine into cellular proteins was examined using the YFK30 strain. The protein synthesis of this strain was highly sensitive to 0.8 mg/ml of CUR (see below; Fig. 4C ). These results suggest that both the protein synthesis and the cell growth of the YFK30 strain are susceptible to CUR. The cells were led to G 1 cell-cycle delay. All these effects of CUR on yeast are analogous to previously reported effects on mammalian cells.
2) Based on these results, we concluded that the YFK30 strain yeast is suitable for investigating the CUR action mechanism.
Isolation and characterization of CUR-resistant mutants
To isolate spontaneous CUR-resistant mutants from the YFK30 parental strain, exponentially growing cells were spread on a YPD-agar plate containing 0.7 mg/ml of CUR, a concentration that inhibited the growth of the parental strain (about 1 Â 10 7 cells per plate). After 3 d of incubation at 30 C, a total of about 500 colonies that appeared on 20 plates were picked up on a YPD plate containing 0.7 mg/ml of CUR for confirmation of resistance. The CUR-resistant strains were then tested for pleiotropic drug resistance by spotting on a plate containing various drugs such as cycloheximide (0.020 mg/ml), 4-nitroquinoline-N-oxide (0.12 mg/ml), rhodamine 6G (2.0 mg/ml), and fluphenazine (28.0 mg/ml). To select for mutants that exhibited CUR-specific resistance, strains that exhibited cross resistance to one or more of these drugs were eliminated. The CURspecific resistant mutants (92 strains) were further classified on the basis of their degree of resistance to CUR by their growth behavior on plates containing various concentrations (0.7, 1.0, 2.0, and 3.0 mg/ml) of the drug. In total, 20 strains were chosen for further analysis, in which the mutants exhibiting various degrees of resistance were included. Each strain was crossed with the parental strain, and the resulting diploids were tested for CUR resistance to determine whether the mutation exhibited a recessive or dominant phenotype. Of the 20 diploid strains examined, five strains exhibited a semi-dominant phenotype for CUR resistance. Tetrad analysis of the spores produced by the diploid strains demonstrated that the spores exhibited a 2:2 segregation pattern for CUR resistance, indicating that the resistance phenotype was due to a single mutation. Next, a complementation analysis was performed by crossing among the haploid strains derived from the five CUR-resistant diploid strains. The result of the analysis demonstrated that all of these mutations belong to a single complementation group, which was designated YCR1 (yeast curvularol resistance). Of the five CUR-resistant mutants, the YCR1-1, -2, and -3 strains showed a higher degree of CUR resistance than the others (YCR1-4, and -5) (Fig. 3 ). All YCR1 strains grew slower than the parental strain (YFK30) at 30 C and 37 C (Fig. 3 ). Next we compared the effect of CUR on the cell growth and FACS profiles of the YCR1-1 and YFK30 strains. Although the growth rate of the YCR1-1 mutant in liquid culture of YPD medium was slower than that of the YFK30 strain, growth was not significantly affected by the presence of 1.0 mg/ml of CUR, a concentration that almost completely inhibited the growth of the parental strain (Fig. 4A) . The slow growth of the YCR1-1 strain was accompanied by an accumulation of cells with 1C DNA (Fig. 4B ). In the presence of 0.8 mg/ml of CUR in the parental strain, the proportion of cells with 1C DNA content increased, but no significant difference was observed in the DNA contents of the YCR1-1 strain in the presence and absence of CUR. Consistently with the observation that CUR is a protein synthesis inhibitor of mammalian cells, protein synthesis as determined by the incorporation of [
35 S] methionine into proteins in the YCR1-1 strain was more resistant to CUR than that in the parental strain (Fig. 4C) .
Cloning of YCR1-1 mutant gene and its identification as an RPL3 allele
To identify and characterize the YCR1 gene product, we cloned the YCR1-1 mutant gene on the basis of its ability to confer CUR resistance to the parental strain due to the semi-dominant nature of the phenotype. A genomic library of the YCR1-1 strain was constructed in YCp50 vector, and the YFK30 parental strain was transformed with the mutant library. The transformants were then tested for their ability to grow on a YPD plate containing 0.7 mg/ml of CUR. A plasmid recovered from the CUR-resistant transformants was confirmed for the ability to confer CUR resistance by re-transformation of the parental strain. Partial sequencing of the inserted fragment revealed that CKA2, YOR062c, and RPL3 ORFs, and parts of YOR060c and YNG1 ORFs, were contained in this fragment. Subcloning of the fragments indicted that the RPL3 gene, which encoded the Rpl3 protein located proximal to the peptidyltransferase center of the 60S ribosomal subunit, was responsible for the resistance. A comparison of the sequences of the mutant and WT proteins indicated that all these mutations caused a replacement of 255Trp residue. In the YCR1-1, -2, and -3 alleles, it was replaced by Cys, and in the YCR1-4, and -5 alleles, it was replaced by Leu. The mutants with the replacement by Cys exhibited higher levels of CUR resistance than that by Leu (Fig. 3) . The Rpl3p ribosomal protein is evolutionarily conserved from prokaryote to eukaryote. A high degree of conservation of Rpl3p among various species of archaebacteria and the eukaryotes has been found. The conservation was especially high in the sequences surrounding the residue 255Trp. 6) To confirm that the CUR resistance caused by the YCR1 mutations was due to the Trp255Cys and Trp255Leu mutations, each mutation was generated using appropriate mutagenic PCR primers as shown in Table 1 . An rpl3Á strain harboring centromeric plasmid carrying a mutant allele was constructed by tetrad analysis of the spores derived from a RPL3/rpl3Á heterodiploid strain (YFK31) transformed with the mutant plasmid. The resistance levels conferred by the mutant plasmids were similar to those of the respective original mutants (Table 2 ). Based on these data, we concluded that the RPL3 mutations are indeed responsible for CUR resistance.
The effect of various substitutions of Trp255 residue of Rpl3p on cell growth and CUR resistance
Because all of the five semi-dominant, CUR-resistant mutant alleles characterized had a replacement of the Trp255 residue by other amino acids, this residue appeared to have a crucial role in the susceptibility of the ribosomes to CUR. To examine the effect of replacement of this residue by other amino acids on cell growth and CUR resistance, we constructed a centromeric plasmid (pRS316) harboring a mutant version of Rpl3p, in which Trp255 residue was replaced by other amino acids, and the plasmids were used to transform rpl3Á strain (see ''Materials and Methods''). The transformants with plasmids carrying the Rpl3p
Trp255Pro or Rpl3p Trp255Asp alleles, however, were not available, suggesting that these mutations cause a severe defect in growth. The effect of various mutant alleles on cell growth in the absence and presence of various concentrations of CUR was compared (Table 2) . Most viable mutants grew slower than the YFK30 parental strain on a YPD plate (without CUR), suggest- Cell suspensions (1 Â 10 7 cells/ml) of various CUR-resistant strains were spotted on YPD-agar plates containing various concentrations of CUR (0, 0.7, or 2.0 mg/ml). In the presence of 2.0 mg/ml of CUR, a five-fold serial dilution of cell suspensions was prepared for the assay. Plates were incubated at 30 C or 37 C for 2 d.
ing that replacement of the Trp255 residue by other amino acids causes various degrees of defect in the ribosomes, but no obvious correlation was noted between the properties of amino acid replaced and the growth rate, except that replacement by a hydrophilic amino acid tended to cause a severer defect than the hydrophobic amino acids with the exception of Arg, which led to a WT-level of growth rate.
All viable replacements conferred CUR resistance to varying extents, showing a high degree of cross- resistance to the trichothecene-family compound verrucarin A. Some of the mutants also showed increased resistance to anisomycin, a peptidyltransferase inhibitor structurally unrelated to trichothecene-family compounds, but CUR and anisomycin cross-resistance was not obvious in most of the mutants (Table 2 ). It was noted that replacement of the Trp255 residue by hydrophobic amino acids and acidic amino acids caused sensitivity to anisomycin. No obvious correlation was noted between the physicochemical properties of the amino acids and the degree of CUR resistance. No clear relationship was observed between the growth rate and the degree of CUR resistance. Of all the mutations compared, the Trp255Cys substitution, which was most frequently isolated by mutant screening (YCR1-1, -2, and -3) showed the highest levels of CUR resistance. The Trp255Gly substitution also conferred a highest level of CUR resistance, but this mutation caused a severe growth defect as well.
The plasmids carrying Trp255Pro or Trp255Asp alleles of Rpl3p (designated pRpl3p
Trp255Asp and pRpl3p
Trp255Pro respectively) failed to suppress the lethality caused by the rpl3Á mutation, suggesting that the mutant alleles cause a severe defect in the ribosomes. But, when the YFK30 strain was transformed with the mutant plasmids, the plasmids conferred increased levels of resistance to CUR, suggesting that mutant alleles promote growth in the presence of CUR (data not shown).
We constructed rpl3Á transformants with the pRpl3p
Trp255Pro or pRpl3p Trp255Asp plasmids by an alternative approach. First, an rpl3Á strain harboring pRpl3p
WT (URA3 marker) was constructed as described above, this strain was further transformed with the pRpl3p
Trp255Pro or pRpl3p Trp255Asp plasmids (TRP1 marker), and the resulting double transformants were maintained on an SD plate (minus Ura and Trp). These double transformants showed a semi-dominant CURresistance phenotype (Fig. 5A) . The double-transformants were then cultivated on a YPD plate with or without CUR to allow elimination of plasmids unfavorable for growth. The plasmids retained in the cells were determined by their markers (Table 3 ). In a control experiment, the double-transformants with the two plasmids both carrying the WT Rpl3p allele, one with a URA3 marker and the other with a TRP1 marker, were cultivated on a YPD plate and examined for plasmids retained. The results showed that the plasmid with a TRP1 marker tended to be retained in the cells better than the plasmid with a URA3 marker, due to the effect of the TRP1 gene in suppressing the partial defect of the erg3Á strain in the uptake of tryptophan from the medium.
5) Nevertheless, our data clearly showed that the mutant plasmids were lost preferentially during cultivation in the absence of CUR, while the WT plasmids were lost preferentially in the presence of CUR (Table 3) . The difference in the rate of plasmid loss might reflect a difference in the negative selective forces The growth rate and drug resistance of the rpl3Á strain (on the YFK30 background) harboring the low-copy plasmid pRS316 carrying various RPL3 mutant alleles, in which Trp255 residue was replaced with other amino acids were examined on YPD-solid medium containing various concentrations of CUR, verrucarin A (VER), and anisomycin (ANI) (see ''Materials and Methods''). Cell growth and no growth on drug-containing plates are indicated by + and À respectively. The amino acids are aligned in increasing order of CUR resistance conferred. The growth rates of various strains in the absence of CUR were evaluated by the numbers 1, 2, and 3, which indicate marginal, intermediate, and near WT-levels growth respectively. 
CUR
conferred by the plasmids under the various conditions (for details, see ''Discussion'' below). Consequently, the rpl3Á strain relying on the pRpl3p Trp255Asp or pRpl3p
Trp255Pro plasmid was obtained after cultivation of the double transformants in the presence of CUR in YPD medium. The transformants with mutant plasmids grew poorly on the YPD plate, but showed increased resistance to CUR (Fig. 5B ). Of these, the Trp255Pro substitution mutant showed the highest level of CUR resistance.
Discussion
Our genetic approaches to identify the target for CUR drug action in yeast have revealed Rpl3p, a ribosomal protein L3 located near the peptidyltransferase center of the 60S subunit, as the target of CUR drug action. All five semi-dominant, CUR-resistant mutations isolated by the screening had a substitution at the Trp255 residue of Rpl3p. This bulky residue of L3 extends proximal to the peptidyltransferase center on the ribosomal large subunit.
6) The RPL3 gene has been identified as the gene responsible for the TCM1 mutation that confers resistance to trichodermin, a member of the trichothecenefamily compounds.
7) The mutation responsible for the TCM1 phenotype was later found to be a Trp255Cys substitution.
8) The TCM1 mutant exhibits cross-resistance to verrucarin A, a trichothecene-family compound, as well as to anisomycin, a peptidyltransferase inhibitor structurally unrelated to trichothecene-family compounds. 7) Because CUR is a trichothecene-related compound, it might be expected that CUR shares common target molecules with trichodermin, but CUR has a characteristic structural difference from ordinary trichothecenefamily compounds. The distance between the epoxide and the double bond moieties of the ring, which are important for their inhibitory effect, is apparently longer in the chemical structures of CUR than in that of trichodermin and other trichothecene-family compounds. Genuine target molecules cannot be predicted, as is known for nucleoside antibiotics. A large number of nucleoside antibiotics with resemblances to adenosine are known to display diverse actions. Some nucleoside antibiotics mimic DNA precursor and are incorporated into DNA to inhibit DNA or RNA synthesis, and some inhibit kinase activities as an ATP analog. In this study, CUR was ultimately found to share a common target with trichodermine. Our results suggest that the configuration of the functional groups of CUR can be similar to those of other trichothecene-family compounds.
Examination of the effect of Trp255 substitution mutations on resistance to peptidyltransferase inhibitors Table 3 . Selective Loss of Low-Copy Plasmids Carrying WT and Mutant RPL3 Allele in the Presence or Absence of CUR The rpl3Á strain (YFK30 background) harboring the low-copy plasmid-carrying WT allele (URA3 marker), together with a plasmid carrying one of the mutant (Rpl3p Trp255Pro or Rpl3p Trp255Asp ) alleles (TRP1 marker), were streaked on YPD plates with or without CUR (1.0 mg/ml) for single-colony isolation. Eight colonies were then selected from each plate and streaked again on a plate of the same kind for single-colony isolation. The plasmids (WT or mutant) retained in each colony were identified by their markers. The number of colonies that grew on each selection plate was divided by the total number of colonies examined. showed a high degree of cross-resistance between CUR and verrucarin A, but not anisomycin (Table 2) . Our data confirmed the observation that the TCM1 trichodermin-resistant mutation (Trp255Cys allele of Rpl3p) shows cross-resistance to anisomycin. Our data showed that other CUR resistant alleles (Trp255 replaced by hydrophobic and acidic amino acids) are not resistant to anisomycin, suggesting the difference in the action mechanisms of the trichothecene-family compounds from that of anisomycin. Trichodermin has been shown to bind to free 80S ribosomes and to polyribosomes, but not to isolated 60S or 40S ribosomal subunits. 9, 10) The binding of [ 14 C] trichodermin to 80S ribosomes was inhibited by anisomycin, suggesting that these compounds share a common binding site.
11) The structure of the anisomycinbound large ribosomal subunit of Haloarcula marimortui was determined at 3.0 Å resolution.
12) The hydrophobic p-methoxyphenyl group of anisomycin binds to the active-site hydrophobic crevice (A-site) on the 60S subunit, which normally accepts the amino acid sidechains of aminoacyl-tRNAs. Anisomycin interferes with the binding of both the A-site substrates and the P-site substrates. Trichothecenes partially prevent the binding of donor and acceptor oligonucleotide substrates to the peptidyltransferase center. 13) Ribosomes isolated from Rpl3
Trp255Cys resistant mutants have been found to possess altered 60S subunits and to become resistant to trichodermin and anisomycin in vitro.
14)
Because CUR has a similarity in structure to trichothecene-family compounds, and Rpl3 mutants show cross-resistance to CUR and verrucarin A, it appears likely that CUR binds and inhibits the 60S ribosomal large subunit in a manner similar to trichodermin. It has been found that anisomycin normally binds to mutant ribosomes with Rpl3
Trp255Cys , whereas trichodermin binds only poorly to mutant ribosomes. 15) Thus trichodermin appears to bind to a site close to but distinct from the binding site for anisomycin at the peptidyltransferase center.
The rpl3Á strain double-transformed with one of the mutant plasmids (pRPL3 Trp255Asp or pRPL3 Trp255Pro ), together with the WT plasmid (pRPL3 WT ) grew apparently normally on the YPD plate, but grew slowly in the presence of a dose of CUR lethal to the WT strain (Fig. 5A) . These effects were unexpected, assuming that composite polyribosomes containing WT and mutant ribosomes are formed in cells expressing both WT and mutant Rpl3p, but these phenomena can be explained in part by a selective loss of the plasmid that has a negative effect on cell growth, as shown in Table 2 . Additionally, it is possible that WT Rpl3p, relative to the mutant counterpart, is preferentially incorporated into the ribosome subunit, and/or that WT ribosomes are preferentially employed for protein synthesis. In the presence of the inhibitor, in contrast, the expression levels of the mutant Rpl3p might be elevated, and/or the mutant Rpl3p might be preferentially incorporated into the ribosomes, and/or the mutant ribosomes might be preferentially employed for protein synthesis.
The physiological effect of CUR on the YFK30 strain may be explained by the inhibition of protein synthesis by CUR. Cells with 1C DNA content accumulated in the CUR-treated YFK30 cells, presumably due to a decreased rate of protein synthesis. Under such conditions, the protein(s), such as the G 1 cyclins, which are essential for cell-cycle progression through the G 1 phase, can become rate-limiting in cell growth, leading to a G 1 cell-cycle delay. 16) In accordance with this notion, the substitution mutations for Cys, His, Lys, Ser, Asn, Gly, and Gln, which caused a slow growth phenotype, led to a G 1 cellcycle delay, presumably due to the decreased rate of protein synthesis caused by the mutant ribosomes (Fig. 4B, and data not shown) . In fact, the Trp255Cys mutation has been shown to cause a defect in peptidyltransferase activity. 6) Our study indicates that the mutant alleles of RPL3 genes exhibit a semi-dominant CUR resistance phenotype (Fig. 5A) , consistent with the fact that the YCR1-1 to -5 CUR-resistant mutations were originally isolated as strains that exhibited a semi-dominant phenotype. In fact, it has been shown that increasing concentrations of deoxynivalenol, a trichothecene group compound, enforce incorporation of Rpl3p
Trp255Cys into the ribosome. 8) 
